Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015
- Author
- The Lancet
- Published
- Thu 02 Apr 2015
- Episode Link
- None
Mahmoud Zureik discusses risk of bleeding in patients with non-valvular atrial fibrillation who switched and those who remained on a vitamin K antagonist.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
